Unilabs Expands Digital Pathology Footprint with Proscia’s Concentriq Platform
Event summary
- Unilabs is deploying Proscia’s Concentriq platform across its European network, with multiple countries already using it for routine case review.
- Unilabs’ pathology network includes 350 experts and 400 laboratory technicians across 12 countries, analyzing 9 million sections annually.
- Concentriq integrates diagnostic data, AI capabilities, and expertise into a single enterprise environment, enabling broader access to Unilabs’ network.
- Proscia’s platform supports Unilabs in advancing precision medicine through seamless interoperability with AI applications.
The big picture
Unilabs’ adoption of Proscia’s Concentriq platform underscores the growing trend of digital transformation in pathology, aiming to enhance precision medicine. This partnership highlights the strategic shift towards integrating AI and diagnostic data to improve patient outcomes, reflecting broader industry movements toward data-driven healthcare solutions. The scale of Unilabs’ network—spanning 12 countries and analyzing millions of pathology sections annually—positions this collaboration as a significant milestone in the evolution of digital pathology.
What we're watching
- Technology Adoption
- The pace at which Unilabs deploys Concentriq across its remaining countries will indicate the scalability of digital pathology solutions.
- Precision Medicine
- How Unilabs integrates AI applications into its diagnostic workflows could set a precedent for other European diagnostic providers.
- Market Expansion
- Whether Proscia can leverage this partnership to expand its footprint beyond Europe into other global markets.
Related topics